Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Phase II Safety and Preliminary Efficacy Study of 2 Dose Regimens of HepaStem in Patients With Acute on Chronic Liver Failure

NCT02946554 is registered in ClinicalTrials.gov with Cellaion SA as lead sponsor.

NCT NCT02946554
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02946554 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Phase II Safety and Preliminary Efficacy Study of 2 Dose Regimens of HepaStem in Patients With Acute on Chronic Liver Failure
Lead sponsor
Cellaion SA
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2016
Completion date
July 31, 2020
Enrollment
24 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

acute-on-chronic liver failure